Genome discoveries pave way for malaria vaccines
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Vaccines to eradicate malaria came a step closer yesterday as scientists unveiled the genomes of the parasite that causes the disease and the mosquito that transmits it.
Together with information extracted from the human genome, researchers will now seek ways to use the knowledge to try to find new treatments, targets and strategies to deal with the disease, which kills up to 2.7 million people every year.
They said it would take money and commitment from pharmaceutical companies and governments, and that it would not be an overnight solution.
Brian Greenwood, professor of tropical medicine at the London School of Hygiene & Tropical Medicine, said: "Attempts to control malaria with drugs and insecticides are in danger of failing because of the problems of resistance, and there is no immediate prospect of a vaccine. It will be a while before the knowledge provided by the projects is translated into practical tools but this will happen and malaria will finally be brought under control."
Robert Sinden, professor of parasite cell biology at Imperial College London, who contributed to the parasite research, said: "This is a fantastic step forward but the real challenge now is for governments and pharmaceutical companies to show that they are prepared to invest the money to control the disease."
The papers detailing the genomes of the parasite Plasmodium falciparum and the the mosquito Anopheles gambiae, appear this week in the journals Nature and Science.
Dr Neil Hall, who led the team at the Wellcome Trust Sanger Institute in Hinxton, Cambridgeshire, which sequenced most of the parasite genome, said: "The amount of data involved was phenomenal.
"It was a bit like tearing up half a dozen Bibles, scattering the pieces over a playing field then trying to put them together again."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments